Figure AI leads the pure-play humanoid robotics sector with a reported $39 billion private valuation.
NEURA Robotics is valued at approximately $7 billion after raising up to $1.4 billion.
Unitree’s planned Shanghai IPO implies a valuation of roughly $5.9 billion to $7 billion, but the final market value is not yet known.
AgiBot is targeting a Hong Kong IPO valuation between $5.1 billion and $6.4 billion.
Rainbow Robotics is a public company with a market capitalisation of approximately $6 billion.
1X and Physical Intelligence may rank highly by reported private valuations, but both are excluded from the pure-play hardware ranking because their latest figures are targets or their businesses are focused primarily on robot intelligence.
The FCC decision does not ban every robot already sold in the US. It mainly creates a barrier for new foreign-produced models seeking authorisation.
The humanoid robotics market is attracting billions of dollars, but the industry’s most viral valuation charts are making the competition look cleaner than it really is.
Figure AI is valued at roughly $39 billion after its latest funding round. Germany’s NEURA Robotics has reached an estimated $7 billion valuation after raising up to $1.4 billion. Unitree and AgiBot are approaching the public markets with multibillion-dollar IPO ambitions.
The problem is that these figures do not all mean the same thing.
Some represent private funding rounds. Others are public market capitalisations or proposed IPO valuations. A few are targets reported by media outlets rather than completed transactions. The result is a ranking that may look precise while mixing several different types of numbers.
The situation became more complicated on July 28, 2026, when the
Federal Communications Commission added foreign-produced advanced robots to its Covered List
. The decision affects new models seeking US equipment authorisation and could reshape which robot makers can launch products in the American market.
Here is a more accurate look at the world’s most valuable humanoid robot companies in 2026, including what their valuations actually represent.
The ranking below uses the latest public valuation, market capitalisation or IPO target available as of August 3, 2026. These figures should not be treated as directly comparable because they come from different types of transactions.
Figure AI remains the most valuable pure-play humanoid robot company by a significant margin.
The company raised more than $1 billion in its Series C funding round in September 2025, giving it a post-money valuation of approximately $39 billion, according to
Figure develops general-purpose humanoid robots for industrial and household use. Its latest model, Figure 03, is designed to work with the company’s Helix artificial intelligence system. Figure says the robot can perform household tasks such as laundry, cleaning and washing dishes.
The company’s valuation reflects more than the hardware itself. Investors are also assigning value to its AI software, training data, partnerships and potential access to the household robotics market.
That makes Figure difficult to compare with companies such as Unitree, which already generates revenue from several robot categories and sells lower-cost products.
NEURA Robotics became one of Europe’s most valuable robotics companies after announcing a Series C financing of up to $1.4 billion in June 2026.
described the financing as the largest funding round ever raised by a full-stack robotics company. The Financial Times reported that the round valued NEURA at approximately $7 billion.
NEURA develops cognitive robots, humanoid platforms and physical AI systems. Its strategy is broader than building a single humanoid model. The company is developing an ecosystem in which different robots can share intelligence and learn from common training environments.
NEURA has said it wants to increase production from thousands of robots to much larger volumes over the coming years. The company is backed by investors including Tether, Qualcomm, Amazon, Nvidia, Bosch and Schaeffler.
Its challenge is similar to that facing most European robotics companies. Raising capital is one step. Building a reliable manufacturing system that can compete with American and Chinese production costs is another.
Unitree’s valuation is one of the clearest examples of why viral robotics charts need more context.
The company was valued at approximately $1.7 billion in an earlier private funding round. It is now preparing to raise around 4.2 billion yuan, or roughly $620 million, through a Shanghai STAR Market IPO.
That offering implies a valuation near $5.9 billion, while some reports have placed the potential value closer to $7 billion.
that the final pricing and terms were still being determined.
Unitree is one of the most commercially visible companies in the sector. It sells humanoid robots such as the G1, as well as quadruped robots and related components. Its products are also significantly cheaper than many Western humanoid platforms.
That commercial reach gives Unitree a different profile from companies valued almost entirely on future deployment potential. However, a proposed IPO valuation is still not the same as a confirmed public market capitalisation.
Unitree has also warned investors that US restrictions could affect its international expansion. The company said current models had received FCC approval, while future models could face additional barriers.
Rainbow Robotics is already a public company, which gives investors a market-based valuation rather than a private funding estimate.
The South Korean company trades on the KOSDAQ under ticker 277810. Its market capitalisation stood at approximately 8.4 trillion Korean won, or around $6 billion, at the end of July 2026, according to
Rainbow Robotics develops robotic systems, mobile platforms and humanoid robotics technology. Samsung Electronics became its largest shareholder after increasing its stake to 35%, with plans to accelerate robot development, including humanoid platforms. Samsung outlined the strategy in its
Rainbow’s valuation is therefore driven partly by public market expectations around Samsung’s robotics strategy. It does not represent the same thing as Figure AI’s private post-money valuation or Unitree’s proposed IPO value.
This is precisely why ranking companies by a single number can be misleading. A public market capitalisation can move every trading day, while a private valuation may remain unchanged until the next funding round.
AgiBot is one of China’s most closely watched humanoid robot companies and has started the process of preparing for a Hong Kong listing.
The company is targeting a valuation between $5.1 billion and $6.4 billion, according to
. Reuters later reported that AgiBot had begun the IPO process in July 2026.
That range is an IPO target, not a confirmed public valuation. The final figure will depend on the prospectus, investor demand, pricing and market conditions.
AgiBot focuses on humanoid robots and embodied artificial intelligence. The company has attracted support from major Chinese investors and has become part of the country’s push to develop domestic robotics champions.
AgiBot illustrates another problem with the viral charts. Some graphics list the company at $6.4 billion, while others use lower figures. Both numbers may refer to different stages of the same IPO process, rather than a contradiction in the company’s actual balance sheet.
Apptronik develops Apollo, a humanoid robot designed for manufacturing, logistics and other industrial environments.
The company reopened its Series A in February 2026 and announced that the round had grown to more than $935 million. Reports placed Apptronik’s valuation above $5.5 billion.
said the new capital would support production, training facilities and commercial deployments.
Apollo has been tested in industrial settings through partnerships involving companies such as Mercedes-Benz and GXO Logistics.
Apptronik is pursuing a more focused strategy than Figure AI. Its main opportunity is not necessarily a household robot. It is the automation of repetitive work in factories, warehouses and distribution centres.
That focus could help the company commercialise earlier. It also limits the size of its initial market compared with companies promising a general-purpose robot for every home.
The main reason the numbers disagree is that the charts are combining at least four different forms of valuation.
A private funding valuation is the value assigned to a company after investors purchase new shares. Figure AI’s $39 billion figure belongs to this category.
It reflects what investors agreed to pay in a specific funding round. It does not mean that the entire company could necessarily be sold for that amount in an open market.
Rainbow Robotics is valued through its share price and total shares outstanding.
This figure changes whenever the company’s stock moves. It also reflects public investor expectations, which can rise sharply when a major company such as Samsung increases its stake.
Unitree and AgiBot are being valued partly through planned IPOs. These numbers represent what the companies hope to achieve when they list shares.
The final figure may be higher or lower once the offering is priced. It can also change after trading begins.
Some private companies are reported to be raising money at a specific valuation before the round is completed.
That applies to 1X, which has been reported to be seeking as much as $1 billion in new funding at a valuation of at least $10 billion. The figure comes from reporting by
, but it should be treated as a target rather than a completed transaction.
This distinction matters because a company can be described as “valued at $10 billion” even when investors have not yet agreed to invest at that price.
The US and China Are Building Different Robotics Advantages
The US and China are competing in humanoid robotics, but they are building different advantages.
American companies such as Figure, Apptronik and Agility Robotics have attracted significant capital from technology, automotive and logistics companies. Their focus is often on artificial intelligence, high-value industrial deployments and integration with existing enterprise systems.
Chinese companies such as Unitree and AgiBot have advantages in manufacturing scale, component supply and lower-cost hardware. They are also developing a wide range of robot models for factories, logistics, education and consumer markets.
This split resembles the wider AI hardware competition.
The US has stronger access to frontier AI capital and software talent. China has a deeper manufacturing ecosystem and a large domestic market for hardware deployment. As
MemeBurn’s report on physical AI and factory robots
noted, commercial adoption will depend on more than demonstrations. It will depend on price, reliability and whether companies can perform useful tasks for long periods without human intervention.
On July 28, the FCC added foreign-produced advanced robotic devices to its Covered List.
The category includes mobile robots such as humanoids and quadrupeds. The FCC said networked robots could create security risks because they may contain cameras, microphones, sensors, connectivity systems and remote-control capabilities.
The action does not mean that every foreign-made robot already in the US must be removed. Devices that already received authorisation are generally treated differently from new models seeking approval. Existing owners and previously authorised products are not automatically affected.
A new foreign-produced robot may be unable to receive the equipment authorisation required for importation, marketing and sale in the US unless it qualifies for an exemption or conditional approval.
That creates an important distinction between company nationality and production origin. A US company may still face regulatory questions if its robot is manufactured overseas. A foreign company may also explore local production or seek a specific exemption.
The FCC decision therefore does not simply create a China versus America ranking. It introduces a new question for every robotics company.
Can the company manufacture and certify its next-generation robot for the US market?
The answer depends on the specific model, where it was produced, when it received authorisation and whether an exemption applies.
Potentially advantaged if production and certification remain US-based
Potentially advantaged through domestic manufacturing partnerships
Focused on US industrial deployments, but model-specific approval still matters
Existing authorised models may continue, while future models face additional barriers
Future foreign-produced models may require approval or an exemption
European origin does not automatically guarantee US clearance
South Korean origin means future models will still require regulatory review
The most important point is that the FCC rules do not automatically make American companies winners.
The companies still need to prove that their robots can work reliably, operate safely around people and reach commercial production. Regulation may create an opening for US manufacturers, but it does not solve the cost and deployment problems facing the industry.
Two names deserve separate treatment because they are often absent from rankings despite attracting major investor interest.
1X, the company behind the NEO humanoid robot, has reportedly explored a funding round of up to $1 billion at a valuation of at least $10 billion.
However, that number is a fundraising target rather than a confirmed completed round. It should not be placed beside Figure AI’s confirmed $39 billion post-money valuation without a clear label.
1X is also pursuing a different market strategy. Its NEO robot is designed for household tasks, while many competitors are focusing on factories and warehouses.
Physical Intelligence develops general-purpose AI models that can control different types of robots. It is therefore closer to an AI platform company than a traditional robot manufacturer.
The company was valued at approximately $5.6 billion in a previous funding round and was later reported to be discussing a new round at a valuation above $11 billion, according to
Physical Intelligence belongs in a broader physical AI ranking, but including it in a pure-play robot maker chart can confuse readers. The company may provide the intelligence layer for robots built by other companies rather than manufacture the machines itself.
The most important data points will not be another viral chart.
Investors and buyers should watch whether companies convert funding into deployed robots, recurring revenue and repeat orders.
The percentage of tasks completed without remote human intervention
The FCC decision adds one more metric to that list.
A company’s ability to legally and commercially enter the US market may become as important as its funding total.
A $6 billion valuation can look impressive on a chart. It becomes harder to defend if a company cannot obtain approval for its next-generation product in one of the world’s most important robotics markets.
The world’s most valuable humanoid robot companies are not ranked on one consistent scale.
Figure AI has a confirmed private valuation of approximately $39 billion. NEURA has reached around $7 billion after a major funding round. Rainbow Robotics has a public market value near $6 billion. Unitree and AgiBot are approaching the public markets with multibillion-dollar targets, while 1X and Physical Intelligence may command even higher private valuations depending on whether their reported fundraising discussions close.
The valuation race is therefore less precise than viral charts suggest.
The bigger story is the intersection of capital, manufacturing, artificial intelligence and regulation. China’s robot makers may have an advantage in scale and cost, while US companies benefit from capital and software ecosystems. The FCC’s decision now adds market access to the competition.
The companies that ultimately lead the industry will need to do more than raise money. They will need to manufacture reliable robots, deploy them in real workplaces and prove that their products can legally operate in the markets they are targeting.
What is the most valuable humanoid robot company in 2026?
Figure AI is currently the most valuable pure-play humanoid robot company, with a reported private valuation of approximately $39 billion after its 2025 Series C funding round.
Unitree’s planned Shanghai IPO implies a valuation of approximately $5.9 billion to $7 billion. This is an IPO valuation estimate rather than a final public market capitalisation.
No. AgiBot began the process of preparing for a Hong Kong IPO in July 2026. The company is reportedly targeting a valuation between $5.1 billion and $6.4 billion.
No. The FCC added foreign-produced advanced robotic devices to its Covered List. The decision mainly affects new models seeking equipment authorisation. Robots that were already authorised are treated differently.
Unitree’s existing authorised models may continue to be sold, but future models could face additional approval barriers under the FCC’s new rules.
Marko is a tech journalist covering AI, consumer technology, crypto, and digital innovation. His work focuses on clear, accessible reporting that helps readers understand how new technologies are shaping business, finance, and everyday life.